Laser treatment of chronic central serous chorioretinopathy with a point of leakage in the subfoveolar zone without fluorescein angiography

Abstract


Aim. Develop a methodology and evaluate the clinical results of laser treatment of patients with chronic central serous chorioretinopathy in the presence of a leakage point in the foveola zone.

Methods. The results of patients (32 eyes) with central serous chorioretinopathy after laser exposure in the avascular area were analyzed. The best-corrected visual acuity in these patients before treatment was 0.7 to 1.0 (average 0.78±0.15) with a height of neuroepithelial detachment of 162 to 328 μm according to optical coherence tomography. No signs of choroidal neovascularization was detected in angio mode on optical coherence tomography. The treatment was performed with an Ellex Integre Pro Scan 561 nm. The follow-up examination was performed in 1 and 6 months.

Results. In 1 month, positive dynamics of both functional and anatomical parameters was noted in all eyes. According to the optical coherence tomography, a complete attachment of the neuroepithelium in the central zone of the retina occurred, detachment of the neuroepithelium was absent. Best-corrected visual acuity in 1 month after treatment increased to 0.89±0.08, in 6 months to 0.92±0.04. The study revealed a correlation between visual acuity and the central thickness of the retina in the fovea, there were no complaints about the appearance of scotomas after laser treatment in the foveola zone.

Conclusion. The developed techniqe of laser exposure on the foveola zone in case of chronic central serous chorioretinopathy with a 561 nm laser demonstrated high clinical efficacy and safety and can be recommended to all patients with central serous chorioretinopathy.


A N Samoylov

Kazan State Medical University

Email: korobicin@yandex.ru
Kazan, Russia

A N Korobitsin

Kord Clinic

Author for correspondence.
Email: korobicin@yandex.ru
Kazan, Russia

  1. Zlobina A.N., Malyshev V.V., Yurʹeva T.N. et al. Indications and effectiveness of different methods of treatment of chronic central serous chorioretinopathy. Sovremennye tekhnologii v oftalʹmologii. 2015; 1: 66–67. (In Russ.)
  2. Malʹtsev D.S., Kulikov A.N. Focal laser coagulation of the leakage point in central serous chorioretinopathy without fluorescein angiography. Sovremennye tekhnologii v oftalʹmologii. 2017; 1: 82–85. (In Russ.)
  3. Park Y.G., Kang S., Kim M. et al. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients. Graefes Arch. Clin. Exp. Ophthalmol. 2017; 255 (7): 1375–1383. doi: 10.1007/s00417-017-3672-3.
  4. Ivanova E.V., Doga A.V., Volodin P.L. et al. The personalized approach to the chronic central serous chorioretinopathy treatment based on the navigated micropulse laser techno­logy. Sovremennye tekhnologii v oftalʹmologii. 2018; 21 (1): 162–165. (In Russ.)
  5. Steve Charles, Jorge Calzada, Byron Wood. Vit­reous microsurgery. Fifth Edition. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania. 2011; 257 p. Russ ed.: Mikrokhirurgiya steklovidnogo tela i setchatki. Ed. by A.N. Samoylov. Moscow: MEDpress-inform. 2012; 400 p. (In Russ.)
  6. Volodin P.L., Zheltov G.I., Ivanova E.V., Solomin V.A. Calibration of the parameters of the micropulse mode ­IRIDEX IQ 577 laser using computer simulation and diagnostic methods of the fundus of the eyes. Sovremennye tekhnologii v oftalʹmologii. 2017; (1): 52–54. (In Russ.)
  7. Shchegoleva I.V., Budzinskaya M.V. Etiology and pathogenesis of central serous chorioretinopathy. Vestnik oftalʹmologii. 2010; 3: ­55–58. (In Russ.)
  8. Mirzabekova K.A., Fedoruk N.A. Lazery v lechenii tsentralʹnoy seroznoy khorioreti-nopatii (Lasers in the treatment of central serous chorioretinopathy). In: Voprosy lazernoy oftalʹmologii. (Issues of laser ophthalmology.) Мoscow. 2013; 249–255. (In Russ.)
  9. Breukink M.B., Dingemans A.J., den Hollander A.I. et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin. Ophthalmol. 2016; 11: 39–46. doi: 10.2147/OPTH.S115685.
  10. Takhchidi Kh.P., Kachalina G.F., Zheltov G.I. et al. Efficiency of a new laser technique of selective retina therapy (SRT) for treatment of structural-functional abnormalities after vitrectomy surgery for retinal detachment. Oftalʹmokhirurgiya. 2010; 2: 35–41. (In Russ.)
  11. Framme C., Walter A., Berger L. et al. Selective retina therapy in acute and chronic-recurrent central serous chorioretinopathy. Ophthalmologica. 2015; 234 (4): ­177–188. doi: 10.1159/000439188.
  12. Sugiura A., Fujino R., Takemiya N. et al. The association between visual function and retinal structure in chronic central serous chorioretinopathy. Sci. Rep. 2017; 7 (1): 16288. doi: 10.1038/s41598-017-16339-9.
  13. Kachalina G.F., Zheltov G.I., Ivanova E.V. Optimization of the modes of the laser IRIS Medical IQ 577 for selective exposure on pigment epithelium of the retina. Oftalʹmologiya. Vostochnaya Evropa. 2015; 27 (4): 69–77. (In Russ.)
  14. Zheltov G.I., Glazkov V.N., Ivanova E.V. Selective effect of laser pulses on the retinal pigment epithelium. Physical basis. ARS-MEDICA. 2012; 58 (3): 78–85. (In Russ.)

Views

Abstract - 20

PDF (Russian) - 17

Cited-By


PlumX


© 2019 Samoylov A.N., Korobitsin A.N.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Свидетельство о регистрации СМИ ЭЛ № ФС 77-75008 от 1 февраля 2019 года выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор)